Cell and Gene Therapy CDMO Services Market 2023 Driving Factors Forecast 2029

According to Precision Business Insights (PBI), the latest report, the cell and gene therapy cdmo services market was valued at USD 5,193.7 million in 2022 and is expected to grow at a17.5% CAGR during the forecast period 2023 to 2029. The primary drivers of the expansion of the global cell and gene therapy CDMO services market include the increasing prevalence of chronic diseases such as cancer, genetic disorders, and autoimmune diseases across the globe. In addition, increasing investments in the launch of new product and clinical trials by the market players is expected to boost the growth of cell and gene therapy CDMO services market.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/cell-and-gene-therapy-cdmo-services-market

Cell Therapy Segment is expected to Dominate the Cell and Gene Therapy CDMO Services Market:
Based on the therapy type, the global Cell and Gene Therapy CDMO Services market is segmented into Cell Therapy (Allogeneic, Autologous, Viral Vector), Gene Therapy (Viral Vectors, Non-viral Vectors). The cell therapy segment is expected to account for a larger revenue share in the global cell and gene therapy CDMO services market. The cell therapy is widely used in the clinical investigation of cardiovascular diseases owing to rigorous pre-clinical studies of cell biology, mechanism of action, phenotypic efficacy, and immunology. However, the allogenic therapy leads to great functionality of cells, and are available readily for studies. Thus, these factors are expected to drive the growth of Cell and Gene Therapy CDMO Services Market in this segment.

The cell and gene therapy cdmo services market is segmented based on therapy type, application, therapeutic area, end user, and geography.
Based on the therapy type, the market is segmented into the following:
• Cell Therapy
• Gene Therapy

Based on the application, the market is segmented into the following:
• Clinical Manufacturing
• Commercial Manufacturing

Based on the therapeutic area, the market is segmented into the following:
• Oncology
• Orthopedics
• infectious disease
• Cardiovascular Disease
• Others

Based on the end user, the market is segmented into the following:
• Pharmaceutical & Biotechnology Companies
• Academics & Research Institutes
• Others

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

North America Cell and Gene Therapy CDMO Services Market:
The North America cell and gene therapy CDMO services market is expected to increase over the forecast period due to the increasing application of gene therapy in diagnostic, therapeutic, drug discovery, and in other research related to oncology and other clinical disorders in United States. In addition, increasing number of geriatric patients, and increasing incidence of infectious diseases in this region are expected to boost the growth of Cell and Gene Therapy CDMO Services Market in this region. Furthermore, increasing research and development activities, and presence of well-established healthcare infrastructure are anticipated to have a positive impact on the market growth over the forecast period.

Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=360585

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global Cell and Gene Therapy CDMO Services market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In February 2021, Charles River Laboratories acquired Cognate Bioservices to increase their capability of cell and gene therapy manufacturing.

Key players profiles in the cell and gene therapy cdmo services market report are Charles River Laboratories, F. Hoffmann-La Roche LTD., FUJIFILM Holdings Corporation, Merck KGaA, Thermo Fisher Scientific Inc, Oxford Biomedica Plc, Cell & Gene Therapy Catapult, Lonza, Catalent, Wuxi App Tec. Takara Bio-Inc.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.